Abstract
Hypoglycaemia is a major side-effect of insulin treatment. It is known that young children with type 1 diabetes mellitus (T1DM) show a higher risk of hypoglycaemia than older children. This study was performed to analyse the incidence of hypoglycaemia within the first 14 days (day 1–day 14) of insulin treatment in children at the onset of T1DM and to evaluate the influence of age and insulin dosage. The Paediatric Quality Initiative (DPV), including data from 121 centres in Germany and Austria, provided anonymous data of 1,680 patients (age 0.7–18.8 years; 799 girls) at the onset of T1DM. Hypoglycaemia was defined as a blood glucose level (BG) <2.8 mmol/l (50 mg/dl). The hypoglycaemia rate rose continuously from day 2 (4.8%) to day 5 (11.2%) and then remained stable between 8.7%–11.2% until day 14. The hypoglycaemia rate was higher in younger than in older children ( P <0.0001). Multiple regression analysis revealed an influence of age ( P <0.0001), insulin dosage ( P =0.0034), and route of initial treatment ( P =0.0052) on the hypoglycaemia rate. From day 2 to day 14, the insulin dosage itself was higher in females than in males ( P =0.0147), in patients with high HbA1c ( P =0.0001), high BG ( P <0.0001), or low pH ( P <0.0001). There was no influence of age on the insulin dosage. Conclusion: During the first 14 days after onset of type 1 diabetes mellitus, young children, intravenous-treated patients and patients receiving a high insulin dosage are at particular risk of developing hypoglycaemia. In order to avoid hypoglycaemia, blood glucose should be measured frequently and the insulin dosage should be carefully adjusted. Low blood glucose levels should be treated promptly.
Similar content being viewed by others
Abbreviations
- BG :
-
blood glucose
- BMI :
-
body mass index
- DKA :
-
diabetic ketoacidosis
- T1DM :
-
type 1 diabetes mellitus
References
Acerini CL, Cheetham TD, Edge JA, Dunger DB (2000) Both insulin sensitivity and insulin clearance in children and young adults with type 1 (insulin-dependent) diabetes vary with growth hormone concentration and with age. Diabetologia 43: 61–68
Craig ME, Handelsman P, Donaghue KC, Chan A, Blades B, Laina R, Bradford D, Middlehurst A, Ambler G, Verge CF, Crock P, Moore P, Silink M, NSW/ACT HbA(1c) Study Group (2002) Predictors of glycaemic control and hypoglycaemia in children and adolescents with type 1 diabetes from NSW and the ACT. Med J Aust 177: 235–238
Diabetes Control and Complication Trial Research Group (1997) Hypoglycemia in the diabetes control and complication trial. Diabetes 46: 271–286
Diabetes Control and Complication Trial Research Group (1998) Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complication trial. A randomized, controlled trial. Ann Int Med 128: 717–523
Grabert M, Schweiggert F, Holl RW (2002) A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV. Computer Methods and Programs in Biomedicine 69: 115–121
Herbst A, Hecker W, Schmidt F, Beinbrech B, Roth C (2003) Hypoglykämien im Rahmen der Erstmanifestation eines Diabetes mellitus Typ 1 (abstract). Diabetes und Stoffwechsel 12: P85
Hoffman RP, Vicini P, Sivitz WI, Cobelli C (2000) Pubertal adolescent male-female differences in insulin sensitivity and glucose effectiveness determined by the one compartment minimal model. Pediatr Res 48: 384–388
International Society for Pediatric and Adolescent Diabetes (ISPAD) (2000) ISPAD consensus guidelines for the management of type 1 diabetes mellitus in children and adolescents. Medical Forum International, Zeist
Komulainen J, Lounamaa R, Knip M, Kaprio EA, Akerbloom HK (1996) Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual ß cell function. Arch Dis Child 75: 410–415
Komulainen J, Akerblom HK, Lounamaa R, Knip M (1998) Prepubertal girls with insulin-dependent diabetes mellitus have higher exogenous insulin requirements than boys. Childhood Diabetes in Finland Study Group. Eur J Pediatr 157: 708–711
Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß HC, Hesse V, v Hippel A, Jaeger U, Johnsen D, Korte W, Menner K, Müller G, Müller JM, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Ziegler A, Hebebrand J (2001) Perzentile für den Body-Mass-Index für das Kinder- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 149: 807–818
McAulay V, Deary IJ, Frier BM (2001) Symptoms of hypoglycaemia in people with diabetes. Diabet Med 18: 690–705
McCrimmon RJ, Gold AE, Deary IJ, Kelnar CJ, Frier BM (1995) Symptoms of hypoglycemia in children with IDDM. Diabetes Care 18: 858–861
Noelle V, Schwarz HP, Kiess W, Raile K (2001) Moderne Behandlungskonzepte für Kinder und Jugendliche mit Diabetes mellitus Typ 1. Monatsschr Kinderheilkd 149: 650–659
Orchard TJ, Becker DJ, Kuller LH, Wagener DK, LaPorte RE, Drash AL (1982) Age and sex variations in glucose tolerance and insulin responses: parallels with cardio-vascular risk. J Chronic Dis 35: 123–132
Acknowledgements
The DPV-Science-Initiative was supported by the German Federal Ministry of Health, Novo Nordisk Germany, the Dr. Bürger-Büsing Foundation and the German Diabetes Foundation. The authors thank the following paediatric diabetes centres having joined the DPV-Science-Initiative and collaborated in this investigation: Aachen, Ahlen, Aue, Augsburg, Aurich, Bad Hersfeld, Bad Oeynhausen, Berlin, Bielefeld, Bonn, Bottrop, Bremen, Bremerhaven, Celle, Chemnitz, Coesfeld, Darmstadt, Datteln, Deggendorf, Delmenhorst, Dortmund, Dresden, Düren-Birkesdorf, Düsseldorf, Erfurt, Erlangen, Essen, Esslingen, Eutin, Freiburg, Fürth, Garmisch-Partenkirchen, Gelsenkirchen, Giessen, Göppingen, Görlitz, Göttingen, Hagen, Halle, Hamburg, Hamm, Hanau, Hannover, Heidelberg, Herdecke, Herford, Hildesheim, Hinrichsegen, Homburg, Itzehoe, Jena, Karlsburg, Karlsruhe, Kassel, Kempen, Kiel, Koblenz, Köln, Landshut, Leipzig, Lingen, Lippstadt, Ludwigsburg, Ludwigshafen, Lübeck, Lüdenscheid, Magdeburg, Mannheim, Marburg, Minden, Moers, Mönchengladbach, München, Münster, Neukirchen, Neuwied, Nürnberg, Oberhausen, Offenbach, Oldenburg, Osnabrück, Paderborn, Pforzheim, Ravensburg, Regensburg, Remscheid, Rendsburg, Rosenheim, Rotenburg/Wümme, Saalfeld, Saarbrücken, Siegen, Sinsheim, Stade, Stuttgart, Suhl, Sylt, Trier, Ulm, Viersen, Waiblingen, Weiden, Weingarten, Wien, Wiesbaden, Worms, Wuppertal.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herbst, A., Roth, C., Dost, A. et al. Rate of hypoglycaemia and insulin dosage in children during the initial therapy of type 1 diabetes mellitus. Eur J Pediatr 164, 633–638 (2005). https://doi.org/10.1007/s00431-005-1723-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-005-1723-y